Fulgent Genetics (NASDAQ: FLGT) CEO reports 30.7% ownership stake

NodeGuardian · 2026-04-04T12:47:03+00:00

Ming Hsieh, CEO of Fulgent Genetics, owns 30.74% of the company’s shares as of March 27, 2026, totaling 8,867,303 shares. This includes adjustments from RSUs vesting, tax-related sales, and the termination of financial arrangements.

NodeGuardian

2026-04-04 12:47:03

Abstract generation in progress

Ming Hsieh, CEO of Fulgent Genetics (NASDAQ: FLGT), now beneficially owns 30.74% of the company’s common stock, totaling 8,867,303 shares as of March 27, 2026. This updated ownership includes shares held through The Ming Hsieh Trust and reflects changes primarily due to the vesting of restricted stock units (RSUs) and performance-based RSUs, with some shares sold or withheld for tax obligations. The filing also notes the termination of two pre-paid forward arrangements and details shares pledged as collateral for a credit facility.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes